Author:
Fury Matthew G.,Sherman Eric,Haque Sofia,Korte Susan,Lisa Donna,Shen Ronglai,Wu Nian,Pfister David
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference40 articles.
1. Bertino J, O’Connor OA (2000) Oncologic disorders. In: Caruthers SG (ed) Clinical pharmacology, 4th edn. McGraw-Hill, New York, pp 799–871
2. Ilson D (2004) Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer. Oncology 18(Suppl 14):22–25
3. Jagasia MH, Langer CL, Johnson DH et al (2001) Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study. Clin Cancer Res 7:68–73
4. Ando M, Kobayashi K, Yoshimura A et al (2004) Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer. Lung Cancer 44:121–127
5. Lippe P, Tummarello D, Monterubbianesi MC et al (1999) Weekly gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase II study. Ann Oncol 10:217–221
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献